Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-249 dose-ranging for osteoporosis pain
NCT00504426Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Jul 2007
- Primary completion
- Jul 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of calcitonin salmon in pain, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Jul 2007; status: completed.
02
Drugs
calcitonin salmon
03
Conditions
pain
Beyond the preview
Go deeper on NCT00504426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504426.